U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Famous Patents

William F. Semple, a dentist, was awarded the first US Patent on chewing gum in 1869. His recipe contained powdered chalk.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 540/477 - Two of the cyclos share at least three ring members or a ring member is shared by three of the cyclos (e.g., bridged, peri-fused, etc.)


Subclass of Class 540 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein (a) at least three members of one cyclo
No. of patents: 75
Last issue date: 03/18/2008


1    
NumberTitleIssue Date
7345056Bridged N-cyclic sulfonamido inhibitors of gamma secretase
The invention provides N-cyclic sulfonamido compounds and salts of Formula I: wherein A is as described in the specification and R1 and R2 combine to form a [3.3.1] or a [3.2.1...
03/18/2008
7314870Compounds, their preparation and use
The present invention relates to novel compounds that are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention ...
01/01/2008
7081531Bridged bicyclic amine derivatives useful as CCR-3 receptor antagonists
Compounds having the formula (I), Ar—(F)-(E)-(CR3R4)—(CHR5)m-(T)-(Q)-Ar1, are useful as CCR-3 receptor antagonists, wherein T is a bridged heterocyclyl group having one N atom and a bridg...
07/25/2006
7057035N-hydroxysuccinimide process for conversion of phenols to carboxamides
A process for converting an aryl triflate, heteroaryl triflate, aryl halide or heteroaryl halide to an N-hydroxysuccinimido ester is disclosed. The process involves reacting the triflate or halide with carbon monoxide and N-hydroxysuccinimide in a solvent in the pre...
06/06/2006
6887868Therapeutic 5-HT ligand compounds
The present invention provides compounds of Formula (I): wherein: R1, R2, R3, R4, R5, R6 R7, R8, n, m, and X have any of the value...
05/03/2005
6849619Substituted pyridoindoles as serotonin agonists and antagonists
The present invention is directed to certain novel compounds represented by structural Formula (I) or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6, R7, ...
02/01/2005
6720316Therapeutic 5-HT ligand compounds
The present invention provides compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and Z have any of the values defined ...
04/13/2004
6699852Substituted pyridoindoles as serotonin agonists and antagonists
The present invention is directed to certain novel compounds represented by structural Formula (I) ##STR1## or pharmaceutically acceptable salt forms thereof, wherein R1, R5, R6, R7, R8, R9...
03/02/2004
6482567Oxime sulfonate and N-oxyimidosulfonate photoacid generators and photoresists comprising same
New photoacid generator compounds ("PAGs") are provided and photoresist compositions that comprise such compounds. In particular, non-ionic PAGs are provided that contain an oxime sulfonate group, and/or an N-oxyimidosulfonate group. PAGs of the invention...
11/19/2002
64654916-phenylpyridyl-2-amine derivatives
The present invention relates to certain 6-phenyl-pyridin-2-ylamine derivatives that exhibit activity as nitric oxide synthase (NOS) inhibitors, to pharmaceutical compositions containing them and to their use in the treatment and prevention of central ner...
10/15/2002
6410534Inhibitors of prenyl-protein transferase
The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds...
06/25/2002
6387512Grey coloring photochromic fused pyrans
A photochromic grey coloring 2H-naphtho[1,2-b]pyran of formula (1) wherein R1 is selected from mono-, di- or poly-substituted aryl groups, mono-, di- or poly-substituted naphthyl groups and mono-, di- or poly-substituted heteroaryl groups, wher...
05/14/2002
6323194Muscarinic agonists and antagonists
The present invention provides novel compounds and pharmaceutical compositions thereof useful in the treatment of pain. The compounds of the present invention are azaadamantanes, azanoradamantanes and azahomoadamantanes....
11/27/2001
62357476-phenyl-pyridin-2-ylamine derivatives
The present invention relates to certain 6-phenyl-pyridin-2-ylamine derivatives that exhibit activity as nitric oxide synthase (NOS) inhibitors, to pharmaceutical compositions containing them and to their use in the treatment and prevention of central ner...
05/22/2001
6211360Ibogamine congeners
The present invention is directed to compounds having formula (1), wherein n is from 0 to 8; R1 is CH2 OH, CH(OH)R5, CH2 OR5, CO2 R5, C(O)NH2, C(I)NHR5, C(O)NR
04/03/2001
6130330Process for preparing macropolycyclic polyamines
What is claimed is a process for preparing macropolycyclic polyamines of the formula ##STR1## where A1, A2, A3 and A4 are as defined in the description. These compounds are prepared by a novel improved proc...
10/10/2000
6048980Process of preparing tetraaza tetraacetic acid
The present invention relates to the novel compound, 1,4,7,10-tetraazabicyclo[8.2.2]tetradecan-2-one of formula (I), its preparation and the use thereof for the preparation of tetraazamacrocycles. ##STR1##...
04/11/2000
6040442Process for preparing 1,2,5-thiadiazole containing ethers
The presently claimed process provides a method for preparing compounds of the formula ##STR1## phosphorous (III) compound and a diester of azodicarboxylate....
03/21/2000
5977129Azacyclic and azabicyclic substituted oxa- or thia-diazole compounds
The present invention relates to compounds of formula I: wherein one or both G is an azacyclic ring of formula II: ##STR1## and Z is oxygen or sulfur and the remaining variables are as defined in the specification. The compounds are useful as stimulants o...
11/02/1999
5952324Bicyclic oxazine and thiazine oxazolidinone antibacterials
Phenyloxazolidinone compound of formula (I)or a pharmaceutically acceptable salt thereof characterized by a bicyclic thiazine or oxazine substituent. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathoge...
09/14/1999
5912343Tertiary amines containing side-chain organolithium structures and method for the preparation thereof
A compound comprising at least one cyclic amine, having an organolithium side-chain, defined according to formula (I) ##STR1## wherein Z is a lithium atom (Li); R1 is selected from the group consisting of organic groups containing from 1 t...
06/15/1999
5854239Diazabicyclic neuokinin antagonists
The present invention relates to diazabicyclic compounds and, specifically, to compounds of the formula ##STR1## wherein A, G, R1, R2, R3, R4, R5, R6, and R7 are as defined ...
12/29/1998
5852189Tertiaryaminoalkyllithium initiators and the preparation thereof
Relatively pure tertiaryaminoalkyllithium initiators suitable for anionic polymerization reactions are prepared at low temperatures in an organic ether by reacting an equivalent excess of lithium metal with a tertiaryaminoalkylhalide. The lithium initiato...
12/22/1998
5849731Indole derivatives and medical application thereof
The present invention relates to indole derivatives represented by the following compound 1 and the pharmacologically acceptable acid addition salt thereof. ##STR1## The compounds of the present invention were found to exhibit strong antitussive...
12/15/1998
5834456Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
Polyazamacrocyclofluoromonoalkylphosphonic acid compounds are disclosed which form inert complexes with Gd, Mn, Fe or La ions. The complexes are useful as contrast agents for diagnostic purposes....
11/10/1998
5834454Substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
A substituted guanidine derivative represented by the general formula: ##STR1## wherein R1, R2, R3 and R4 are independently a hydrogen atom, an unsubstituted alkyl group, a substituted alkyl group, a halogen ...
11/10/1998
5744607Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
The invention is directed to glutamic acid and aspartic acid derivatives represented by formula (I): ##STR1## wherein R1 is selected from the group consisting of unsubstituted, mono- or di-substituted phenyl groups, unsubstituted, mono- or...
04/28/1998
5741788Heterocyclic compounds and their preparation and use
The present invention relates to therapeutically active azacyclic or azabicyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nerv...
04/21/1998
5733924DC 107 derivatives and treatment methods
DC107 derivatives represented by the formula (I): ##STR1## or pharmacologically acceptable slats thereof, ›wherein R1 is hydrogen, lower alkoxyalkyl, aralkyloxyalkyl, lower alkoxyalkoxyalkyl, lower alkoxyalkoxyalkoxyalkyl, aralkyl, tetrah...
03/31/1998
5728843(2'-nitro-1'-imidazolyl)-2,3-isopropylidene-y-tosylbutanol, a precursor to ›18 F!fluoroerythronitroimidazole PET imaging agent
The present invention involves a rapid synthesis of 18 F-FMISO and analogs thereof. New precursors such as 1-(2'-nitro-1'-imidazolyl)-2-0-acetyl-3-0-tosylpropanol, glycerol-1,3-ditosylate-2-0-acetylate, 1-(2'-nitro-1'-imidazolyl)-2,3-0-dia...
03/17/1998
5707985Naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives as cell adhesion modulators
There are disclosed novel substituted naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives that are useful in a method of treating immuno-inflammatory diseases in a mammalian patient suffering therefrom. Pharmaceutical compositions containing the...
01/13/1998
5679673Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
Certain aralkyl diazabicycloalkyl compounds are described for treatment of CNS disorders such as cerebral ischemia, psychoses and convulsions. Compounds of particular interest are of the formula: ##STR1## wherein each of R, R1, R4
10/21/1997
5643848Soluble anionic polymerization initiators and products therefrom
An acyclic alkane soluble anionic polymerization initiator includes a mixture of from about 90 to about 10 parts by weight of a lithio amine having the general formula A1 Li and from about 10 to about 90 parts by weight of at least one other li...
07/01/1997
5578542Soluble anionic polymerization initiators and method of preparing same
An acyclic alkane soluble anionic polymerization initiator includes a mixture of from about 90 to about 10 parts by weight of a lithio amine having the general formula A1 Li and from about 10 to about 90 parts by weight of at least one other li...
11/26/1996
5512579Aminobenzoic acid derivatives
To provide a compound which exhibits a serotonin antagonism and an acetylcholine release accelerating activity at a well-balanced activity ratio. An aminobenzoic acid derivative represented by the general formula (I) or (II) or a pharmacologically accepta...
04/30/1996
5498614Bridged aza-bicyclic derivatives as substance P antagonist
The invention relates to bridged aza-bicyclic derivatives of formula (I). These compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders. Also disclosed are intermediates used in the synthesis ...
03/12/1996
5414009Azabicyclo substituted oxa- or thia-diazole compounds
The present invention relates to compounds ##STR1## where G is ##STR2## and Z is oxygen or sulfur and the remaining variables are as defined in the Specification. The compounds are useful as stimulants of the cognitive function of the foreb...
05/09/1995
5352685Thieno[3,2-b]pyridine derivatives
The thieno[3.2-b]pyridine derivative of the present invention promote the gastric emptying in male ddy mice and the gastric contraction in dogs sutured with a strain-gauge transducer. It is believed that the derivatives have the action to enhance gastric ...
10/04/1994
5329005Soluble anionic polymerization initiators and preparation thereof
The present invention is directed toward anionic polymerization initiators which are soluble in hydrocarbon solvents. The initiators include a lithio amine having the general formula ALi. The component A is a dialkyl or dicycloalkyl amine radical or a cyc...
07/12/1994
5256671Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
Compounds of formula (I), and salts and prodrugs thereof: ##STR1## wherein Q is the residue of an optionally substituted azabicyclic ring system; the dotted line represents an optional double bond; X represents H, --OH, .dbd.O or halo; R1 repre...
10/26/1993
1    
 
Sign InRegister
Username  
Password   
forgot password?